Health
Magic Mushrooms Get Canadian Export License in Psychedelic Race
- Startup making mushrooms and MDMA gets green light for sales
- Lululemon founder’s son JJ Wilson betting on psilocybin demand
The market today is clinical rather than recreational.
Photographer: Moriah Ratner/BloombergThis article is for subscribers only.
Canada has licensed a startup to export psychedelics to Australia for patient use, the latest milestone in a contest to supply the potential growth of medical psychedelic drugs.
Canada’s health department awarded a drug establishment license to Optimi Health Corp., a spokeswoman for the company said, allowing it to ship pills containing the magic-mushroom extract psilocybin and MDMA — controlled and otherwise-illegal substances — to a provider in Australia.